Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
11.74
-0.30 (-2.49%)
Aug 26, 2026, 4:00 PM EDT - Market closed
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $697.17 million as of August 27, 2026. Its market cap has increased by 32.69% in one year.
Market Cap
697.17M
Enterprise Value
477.09M
1-Year Change
32.69%
Ranking
Category
Stock Price
$11.74
ChartMarket Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $697.17M, an increase of 405.93%. That is a compound annual growth rate of 15.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 697.17M | 38.22% |
| Dec 31, 2025 | 504.40M | 13.30% |
| Dec 31, 2024 | 445.20M | 87.69% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
| Apr 16, 2015 | 137.80M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Oncology Therapeutics | 751.23M |
| Allogene Therapeutics | 749.72M |
| Monopar Therapeutics | 743.84M |
| Tectonic Therapeutic | 737.21M |
| CytomX Therapeutics | 734.32M |
| Crescent Biopharma | 727.62M |
| Assembly Biosciences | 719.34M |
| Gyre Therapeutics | 708.31M |